Literature DB >> 31527322

Association of Fetuin-B with Subclinical Atherosclerosis in Obese Chinese Adults.

Zhibin Li1, Chunmei He2, Yongwen Liu3, Dongmei Wang4, Mingzhu Lin5, Changqin Liu5,6, Xiulin Shi5, Zheng Chen5, Xuejun Li5, Shuyu Yang2, Weihua Li7.   

Abstract

AIM: We aimed to explore the independent associations of serum Fetuin-B and common genetic variants in FETUB locus with subclinical atherosclerosis.
METHODS: A cross-sectional study of 1,140 obese adults, who underwent serum Fetuin-B testing, hepatic ultrasonography scanning, genotyping on four tagging single nucleotide polymorphisms (SNPs) in FETUB locus and atherosclerosis detection, was conducted in Xiamen, China.
RESULTS: Increasing tertiles of brachial ankle pulse wave velocity (ba-PWV) were significantly associated with higher prevalence of nonalcoholic fatty liver disease (NAFLD) (48.8%, 61.5%, and 70.5% for tertiles of 1-3, respectively, p<0.001) and serum Fetuin-B (3.85±1.39, 4.09±1.40, and 4.27±1.46 µg/ml, p=0.047). Multivariable linear regression analyses with adjustment for potential confounding factors, even NAFLD per se, showed that serum Fetuin-B were significantly and positively associated with ba-PWV, with standardized regression coefficients (β) ranging from 0.055 to 0.075 (all p-values <0.05) in different models. However, the significant relationship between serum Fetuin-B and ba-PWV disappeared with further adjustment for insulin resistance. Serum Fetuin-B was not significantly associated with ankle-brachial index (ABI). All genotypes of the four tested FETUB tagging SNPs were not significantly associated with either ba-PWV or ABI with adjustment for potential confounding factors.
CONCLUSION: Serum Fetuin-B was positively associated with ba-PWV and may link liver fat accumulation to subclinical atherosclerosis via insulin resistance.

Entities:  

Keywords:  Ankle-brachial index; Atherosclerosis; Brachial ankle pulse wave velocity; Fetuin-B; Single nucleotide polymorphism

Mesh:

Substances:

Year:  2019        PMID: 31527322      PMCID: PMC7242228          DOI: 10.5551/jat.49619

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  25 in total

Review 1.  Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease.

Authors:  Jun Luo; Li Xu; Jiang Li; Shuiping Zhao
Journal:  Eur J Gastroenterol Hepatol       Date:  2015-03       Impact factor: 2.566

Review 2.  Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association.

Authors:  Victor Aboyans; Michael H Criqui; Pierre Abraham; Matthew A Allison; Mark A Creager; Curt Diehm; F Gerry R Fowkes; William R Hiatt; Björn Jönsson; Philippe Lacroix; Benôit Marin; Mary M McDermott; Lars Norgren; Reena L Pande; Pierre-Marie Preux; H E Jelle Stoffers; Diane Treat-Jacobson
Journal:  Circulation       Date:  2012-11-16       Impact factor: 29.690

Review 3.  Insulin resistance, hyperglycemia, and atherosclerosis.

Authors:  Karin E Bornfeldt; Ira Tabas
Journal:  Cell Metab       Date:  2011-11-02       Impact factor: 27.287

4.  Serum fetuin-B is positively associated with intrahepatic triglyceride content and increases the risk of insulin resistance in obese Chinese adults: A cross-sectional study.

Authors:  Dongmei Wang; Yijie Liu; Suhuan Liu; Lin Lin; Changqin Liu; Xiulin Shi; Zheng Chen; Mingzhu Lin; Shuyu Yang; Zhibin Li; Xuejun Li
Journal:  J Diabetes       Date:  2018-01-05       Impact factor: 4.006

5.  The hepatokines fetuin-A and fetuin-B are upregulated in the state of hepatic steatosis and may differently impact on glucose homeostasis in humans.

Authors:  Andreas Peter; Marketa Kovarova; Harald Staiger; Jürgen Machann; Fritz Schick; Alfred Königsrainer; Ingmar Königsrainer; Erwin Schleicher; Andreas Fritsche; Hans-Ulrich Häring; Norbert Stefan
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-11-14       Impact factor: 4.310

6.  The rs4686434 variant in the fetuin B (FETUB) locus is associated with intrahepatic triglyceride content in obese Chinese adults.

Authors:  Zhibin Li; Mingzhu Lin; Changqin Liu; Zheng Chen; Dongmei Wang; Xiulin Shi; Shuyu Yang; Xue-Jun Li
Journal:  J Diabetes       Date:  2018-05-22       Impact factor: 4.006

7.  Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease.

Authors:  Teoman Dogru; Halil Genc; Serkan Tapan; Fatih Aslan; Cemal Nuri Ercin; Fatih Ors; Muammer Kara; Erdim Sertoglu; Yildirim Karslioglu; Sait Bagci; Ismail Kurt; Alper Sonmez
Journal:  Clin Endocrinol (Oxf)       Date:  2013-05       Impact factor: 3.478

8.  The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients.

Authors:  Cláudio C Mottin; Myriam Moretto; Alexandre V Padoin; Aline M Swarowsky; Marcelo G Toneto; Luiz Glock; Giuseppe Repetto
Journal:  Obes Surg       Date:  2004-05       Impact factor: 4.129

9.  Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke.

Authors:  Cornelia Weikert; Norbert Stefan; Matthias B Schulze; Tobias Pischon; Klaus Berger; Hans-Georg Joost; Hans-Ulrich Häring; Heiner Boeing; Andreas Fritsche
Journal:  Circulation       Date:  2008-11-24       Impact factor: 29.690

Review 10.  Hepatokines as a Link between Obesity and Cardiovascular Diseases.

Authors:  Hye Jin Yoo; Kyung Mook Choi
Journal:  Diabetes Metab J       Date:  2015-02       Impact factor: 5.376

View more
  2 in total

1.  DIA-Based Proteomic Analysis of Plasma Protein Profiles in Patients with Severe Acute Pancreatitis.

Authors:  He Li; Yansong Xu; Xin Zhou; Taiyang Jin; Ziru Wang; Yuansong Sun; Haiping Wang; Datong Jiang; Chunlin Yin; Bing Shen; Kai Song
Journal:  Molecules       Date:  2022-06-17       Impact factor: 4.927

2.  Level of Serum Fetuin-A Correlates with Heart Rate in Obstructive Sleep Apnea Patients without Metabolic and Cardiovascular Comorbidities.

Authors:  Elżbieta Reichert; Jerzy Mosiewicz; Wojciech Myśliński; Andrzej Jaroszyński; Agata Stanek; Klaudia Brożyna-Tkaczyk; Barbara Madejska-Mosiewicz
Journal:  Int J Environ Res Public Health       Date:  2022-05-25       Impact factor: 4.614

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.